Best TWAS P=1.05e-10 · Best GWAS P=1.73e-12 conditioned to 0.0125
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | HPCA | 0.11 | 0.09 | bslmm | 279 | 0.10 | 1.0e-11 | -5.2 | 5.2 | 2.5e-07 | 0.03 | 0.46 | 0.54 | TRUE |
2 | CommonMind | Brain Pre-frontal Cortex | S100PBP | 0.05 | 0.04 | enet | 10 | 0.02 | 1.2e-03 | -6.3 | 5.4 | 5.1e-08 | -0.01 | 0.01 | 0.99 | FALSE |
3 | CommonMind | Brain Pre-frontal Cortex | TMEM54 | 0.05 | 0.00 | blup | 281 | 0.02 | 4.5e-03 | 0.8 | -6.5 | 1.1e-10 | -0.03 | 0.10 | 0.30 | TRUE |
4 | CommonMind | Brain Pre-frontal Cortex | ZNF362 | 0.05 | 0.06 | lasso | 1 | 0.06 | 2.2e-07 | -5.5 | -5.5 | 4.2e-08 | -0.04 | 0.36 | 0.64 | FALSE |
5 | GTEx | Cells EBV-transformed lymphocytes | PHC2 | 0.58 | 0.34 | lasso | 7 | 0.28 | 7.3e-10 | -5.6 | 5.6 | 1.7e-08 | 0.04 | 0.11 | 0.89 | FALSE |
6 | GTEx | Muscle Skeletal | FNDC5 | 0.15 | 0.16 | enet | 5 | 0.16 | 1.9e-15 | -6.0 | -6.0 | 2.4e-09 | 0.01 | 0.03 | 0.97 | FALSE |
7 | GTEx | Thyroid | BAI2 | 0.31 | 0.23 | lasso | 6 | 0.22 | 1.4e-16 | 6.4 | 6.5 | 1.0e-10 | 0.81 | 0.20 | 0.80 | TRUE |
8 | GTEx | Thyroid | TMEM54 | 0.10 | 0.09 | lasso | 7 | 0.07 | 3.3e-06 | -5.2 | 5.2 | 1.7e-07 | -0.01 | 0.42 | 0.58 | FALSE |
9 | ROSMAP | Brain Pre-frontal Cortex | PHC2 | 0.11 | 0.07 | lasso | 3 | 0.05 | 2.2e-07 | -5.6 | -5.2 | 1.7e-07 | -0.03 | 0.13 | 0.87 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FNDC5 | 0.02 | 0.01 | blup | 33 | 0.01 | 9.2e-03 | -4.3 | -5.2 | 1.6e-07 | -0.01 | 0.01 | 0.53 | FALSE |
11 | The Cancer Genome Atlas | Breast Invasive Carcinoma | S100PBP | 0.03 | 0.02 | blup | 46 | 0.02 | 6.6e-06 | -6.2 | 5.9 | 4.8e-09 | -0.02 | 0.01 | 0.99 | FALSE |
12 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | S100PBP | 0.06 | 0.03 | blup | 48 | 0.06 | 6.8e-04 | -6.1 | 6.4 | 1.4e-10 | 0.00 | 0.01 | 0.81 | FALSE |
13 | The Cancer Genome Atlas | Glioblastoma Multiforme | S100PBP | 0.21 | 0.15 | lasso | 5 | 0.15 | 2.9e-05 | -6.0 | 6.0 | 2.6e-09 | -0.01 | 0.01 | 0.92 | FALSE |
14 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | S100PBP | 0.04 | 0.04 | lasso | 4 | 0.04 | 2.3e-05 | -6.2 | 6.2 | 5.1e-10 | -0.01 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | FNDC5 | 0.03 | 0.04 | enet | 6 | 0.03 | 2.9e-04 | -6.1 | -5.6 | 2.1e-08 | 0.03 | 0.01 | 0.98 | FALSE |
16 | The Cancer Genome Atlas | Brain Lower Grade Glioma | S100PBP | 0.06 | 0.06 | blup | 47 | 0.05 | 5.2e-06 | -6.2 | 6.2 | 4.6e-10 | 0.02 | 0.01 | 0.99 | FALSE |
17 | The Cancer Genome Atlas | Lung Adenocarcinoma | COL16A1 | 0.04 | 0.03 | lasso | 4 | 0.03 | 5.2e-04 | 6.5 | -5.5 | 3.2e-08 | -0.82 | 0.03 | 0.79 | FALSE |